Preventing clinically important deterioration with single-inhaler triple therapy in COPD

समान संसाधन

• Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial
  द्वारा: Ismaila, Afisi S., और अन्य
  प्रकाशित: (2017)
• Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
  द्वारा: Halpin, David M.G., और अन्य
  प्रकाशित: (2018)
• Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: An Integrated Post Hoc Analysis
  द्वारा: Naya, Ian P., और अन्य
  प्रकाशित: (2018)
• Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
  द्वारा: Tabberer, Maggie, और अन्य
  प्रकाशित: (2018)
• Measuring disease activity in COPD: is clinically important deterioration the answer?
  द्वारा: Singh, Dave, और अन्य
  प्रकाशित: (2020)